StockData
Spruce Biosciences, Inc. logo

Spruce Biosciences, Inc. (SPRB) stock

SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$43.31+0.42 (+0.98%)

Close on Nov 13, 2026Market cap $124.47MP/E –Yield –

Spruce Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Spruce Biosciences's price to sales ratio was 62.7× on Jan 30, 2026, against 163.6× a year earlier. Over the last 3 years it ranged from 1.6× to 238.4×, with a median of 22.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202662.7×−7.7
2025Dec 31, 202570.4×+68.0
2024Dec 31, 20242.4×−14.1
2023Dec 29, 202316.6×–

More Spruce Biosciences figures

See a number that looks wrong?